Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
21.27
-0.35 (-1.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Thera CS
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
10 Biggest Price Target Changes For Tuesday
June 29, 2021
Barclays raised the price target for Skyworks Solutions, Inc. (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
June 29, 2021
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to...
Via
Benzinga
Intellia Seeks To Raise $400M Via Equity
June 29, 2021
Intellia Therapeutics Inc (NASDAQ: NTLA) commenced an underwritten public offering of $400 million shares of its common stock. Underwriters have an option to...
Via
Benzinga
60 Biggest Movers From Yesterday
June 29, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its...
Via
Benzinga
Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know
June 28, 2021
An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher
June 28, 2021
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intellia Makes a Splash, Bringing Other CRISPR Stocks Along for the Ride
June 28, 2021
Intellia's recent press release reveals first-of-its-kind clinical results for genome editing technology, leading NTLA stock skyward.
Via
InvestorPlace
Ignoring Monday's 2 Big Nasdaq Winners Could Cost You Serious Money
June 28, 2021
Find out why these stocks are climbing higher.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA
Via
Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump
June 28, 2021
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Beam Therapeutics Jumped Today
June 28, 2021
A first for CRISPR-Cas9 might signal a new phase in the gene-editing revolution.
Via
The Motley Fool
Why Editas Medicine Stock Is Jumping Today
June 28, 2021
Good news for Intellia was viewed as good news for Editas.
Via
The Motley Fool
44 Stocks Moving In Monday's Mid-Day Session
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...
Via
Benzinga
Why Intellia Therapeutics Stock Is Skyrocketing Today
June 28, 2021
The company reported promising interim trial results for its CRISPR gene-editing candidate.
Via
The Motley Fool
Intellia Stock Leads Biotech Rally On Historic Moment For CRISPR
June 28, 2021
Intellia led a rally for CRISPR stocks on Monday on early promise for its gene-editing drug. The news sent NTLA stock to a record high.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Monday
June 28, 2021
During the morning session on Monday, 118 stocks hit new 52-week highs. Highlights: The company with the largest market cap to set a new 52-week high was Microsoft...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook
June 28, 2021
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Intellia Therapeutics Stock Is Soaring Today
June 28, 2021
Intellia Therapeutics Inc (NASDAQ:NTLA) is trading signifi...
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 28, 2021
Barclays raised the price target for Accenture plc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion....
Via
Benzinga
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
June 28, 2021
Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics.
Via
InvestorPlace
24 Stocks Moving in Monday's Pre-Market Session
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim...
Via
Benzinga
Intellia Shares Shoot Higher On Promising Biomarker Data From CRISPR/Cas9 Genome Editing Candidate
June 28, 2021
Intellia Therapeutics Inc (NASDAQ: NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have announced positive interim data from an ongoing Phase 1...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower
June 28, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged more than 230 points in the previous session. The S&P 500 index also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Expert Ratings For Intellia Therapeutics
June 23, 2021
Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1...
Via
Benzinga
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company
June 22, 2021
From
Blackstone
Via
Business Wire
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.